FIELD: medicine, ophthalmology.
SUBSTANCE: the suggested ophthalmic composition contains ketothiphen salt, nonionic agent to regulate tonicity in the quantity that total tonicity of composition should correspond to osmolarity of 210-290 mOsm, a conserving agent, not obligatory, either acid or foundation to achieve pH value being slightly acid and water, moreover, if the mentioned conserving agent is not available, the concentration of ketothiphen salt should correspond to 0.01-0.04 weight%, or if the mentioned conserving agent is available, the concentration of ketothiphen salt should correspond to 0.01-0.03 weight%. As ketothiphen salt the suggested composition contains ketothiphen fumarate; tonicity should be controlled with nonionic agent - glycerol.
EFFECT: more prolonged action of the composition suggested.
15 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABILIZED AND CONSERVED EYE COMPOSITIONS CONTAINING KETOTIFEN | 2006 |
|
RU2442583C2 |
| OPHTHALMIC COMPOSITION | 2012 |
|
RU2639472C2 |
| STABILISED OPHTHALMIC COMPOSITIONS OF KETOTIFEN CONTAINING PRESERVING AGENT | 2006 |
|
RU2444361C2 |
| COMPOSITIONS AND METHODS USED FOR DECREASING OCULAR HYPERTENSION | 1998 |
|
RU2197970C2 |
| ASCOMYCIN-CONTAINING OPHTHALMIC COMPOSITION | 2002 |
|
RU2313344C2 |
| OPHTHALMIC COMPOSITION WITH HIGH CONCENTRATION OF OLOPATADINE | 2012 |
|
RU2613715C2 |
| OPHTHALMIC COMPOSITIONS AND METHODS OF TREATING EYES | 2005 |
|
RU2410081C2 |
| KETOTHIPHEN OPTICALLY ACTIVE ISOMERS AND THEIR THERAPEUTICALLY ACTIVE METABOLITES | 2000 |
|
RU2266115C2 |
| PHARMACEUTICAL COMPOSITIONS AND METHODS FOR APPLICATION OF 4-PREGNEN-11β-17-21-TRIOL-3,20-DIONE DERIVATIVES | 2012 |
|
RU2683775C2 |
| FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
